eprazinone has been researched along with Tuberculosis, Pulmonary in 1 studies
eprazinone : A member of the class of piperazines in which the two amino hydrogens of piperazine are replaced by 2-benzoylpropyl and 2-ethoxy-2-phenylethyl groups.
Tuberculosis, Pulmonary: MYCOBACTERIUM infections of the lung.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Opl, G | 1 |
1 other study available for eprazinone and Tuberculosis, Pulmonary
| Article | Year |
|---|---|
[Clinical use of eprazinon-dihydrochloride (Eftapan)].
Topics: Antitubercular Agents; Bronchitis; Drug Evaluation; Humans; Male; Piperazines; Propiophenones; Respi | 1978 |